Short Interest in Moolec Science SA (NASDAQ:MLEC) Grows By 56.9%

Moolec Science SA (NASDAQ:MLEC - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 8,000 shares, an increase of 56.9% from the March 31st total of 5,100 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,360,000 shares, the days-to-cover ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, Maxim Group initiated coverage on Moolec Science in a research note on Tuesday, January 30th. They set a "buy" rating and a $6.00 target price for the company.

Get Our Latest Analysis on MLEC

Moolec Science Stock Performance

Shares of MLEC stock traded up $0.03 during trading hours on Friday, hitting $1.45. 308,796 shares of the company's stock were exchanged, compared to its average volume of 4,393,164. The company has a current ratio of 0.43, a quick ratio of 0.37 and a debt-to-equity ratio of 0.89. The firm has a 50 day moving average of $1.53 and a two-hundred day moving average of $2.08. Moolec Science has a fifty-two week low of $1.15 and a fifty-two week high of $4.40.

Moolec Science (NASDAQ:MLEC - Get Free Report) last posted its quarterly earnings data on Wednesday, March 13th. The company reported ($0.05) EPS for the quarter, meeting the consensus estimate of ($0.05). The firm had revenue of $0.25 million during the quarter, compared to analyst estimates of $0.63 million.

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.

Further Reading

→ America’s worst nightmare? (From Porter & Company) (Ad)

Should you invest $1,000 in Moolec Science right now?

Before you consider Moolec Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moolec Science wasn't on the list.

While Moolec Science currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: